Skip to content

Other

METHOXY PEG-2000 BILIRUBINAMIDE

48

Safety score · 0–100

Moderate

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

About

A long-chain PEG-2000 ethoxylated bilirubinamide analogue with very limited safety information, posing similar concerns to its shorter-chain PEG-36 counterpart.

Methoxypolyethylene glycol 2000 bilirubinamide shares the same bilirubinamide core as the PEG-36 variant but carries a substantially longer polyethylene glycol chain (average MW 2000). High-MW PEG derivatives are generally considered low risk for systemic absorption due to their size, but concerns regarding residual monomers, peroxidation of PEG chains on storage, and unknown ecological profiles persist. No EU CosIng entry or safety assessment was found for this specific ingredient.

Skin benefits

  • Potential antioxidant activity from bilirubin scaffold
  • High MW PEG may contribute to film-forming humectant effect

Known concerns

  • No established EU safety assessment or authorised use
  • Potential for PEG peroxidation by-products over time
  • Residual monomer content from polymerisation

References

EU

EU CosIng database

European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.

Related others

Check your shelf

Find METHOXY PEG-2000 BILIRUBINAMIDE in your products.

Scan any cosmetic product with LuxSense to see if it contains METHOXY PEG-2000 BILIRUBINAMIDE and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.